← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2016Last known activity
Oct 18, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 7 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07277153Sponsor investigatorPhase 4Oct 18, 2025
- NCT07277153CollaboratorPhase 4Oct 18, 2025
- NCT07277153Lead sponsorPhase 4Oct 18, 2025
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT06905561Lead sponsorN/AFeb 13, 2025
- NCT06095570Lead sponsorPhase 4Jul 23, 2022
- NCT06095570OfficialPhase 4Jul 23, 2022
- NCT03720496Overall official - principal investigatorPhase 1Nov 1, 2018
- NCT03649529Overall official - principal investigatorEarly Phase 1Sep 15, 2018
- NCT03649529CollaboratorEarly Phase 1Sep 15, 2018
- NCT02998242CollaboratorN/AMay 1, 2016
Details
- Last known activity
- Oct 18, 2025